Gibson Bryan, Simonsen Sara, Barton Jonathan, Zhang Yue, Altizer Roger, Lundberg Kelly, Wetter David W
Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, United States.
College of Nursing, University of Utah, Salt Lake City, UT, United States.
JMIR Res Protoc. 2021 Jun 14;10(6):e28884. doi: 10.2196/28884.
More than 88 million Americans are at risk of developing type 2 diabetes mellitus (T2DM). The National Diabetes Prevention Program's Lifestyle Change Program (DPP LCP) has been shown to be effective in reducing the risk of progressing from prediabetes to T2DM. However, most individuals who could benefit from the program do not enroll.
The aim of this trial is to test the real-world efficacy of 3 mobile phone-based approaches to increasing enrollment in the DPP LCP including a best-practice condition and 2 novel approaches.
We will conduct a 3-armed randomized clinical trial comparing enrollment and 1-month engagement in the DPP LCP among adults with prediabetes from 2 health care settings. Participants in the best-practice condition will receive SMS-based notifications that they have prediabetes and a link to a website that explains prediabetes, T2DM, and the DPP LCP. This will be followed by a single question survey, "Would you like the DPP LCP to call you to enroll?" Participants in the 2 intervention arms will receive the same best-practice intervention plus either 2 mobile 360° videos or up to 5 brief phone calls from a health coach trained in a motivational coaching approach known as Motivation and Problem Solving (MAPS). We will collect measures of diabetes-related knowledge, beliefs in the controllability of risk for T2DM, risk perceptions for T2DM, and self-efficacy for lifestyle change pre-intervention and 4 weeks later. The primary outcomes of the study are enrollment in the DPP LCP and 4-week engagement in the DPP LCP. In addition, data on the person-hours needed to deliver the interventions as well as participant feedback about the interventions and their acceptability will be collected. Our primary hypotheses are that the 2 novel interventions will lead to higher enrollment and engagement in the DPP LCP than the best-practice intervention. Secondary hypotheses concern the mechanisms of action of the 2 intervention arms: (1) whether changes in risk perception are associated with program enrollment among participants in the mobile 360° video group and (2) whether changes in self-efficacy for lifestyle change are associated with program enrollment among participants in the MAPS coaching group. Finally, exploratory analyses will examine the cost effectiveness and acceptability of the interventions.
The project was funded in September 2020; enrollment began in February 2021 and is expected to continue through July 2022.
We are conducting a test of 2 novel, scalable, mobile phone-based interventions to increase enrollment in the DPP LCP. If effective, they have tremendous potential to be scaled up to help prevent T2DM nationwide.
ClinicalTrials.gov NCT04746781; https://clinicaltrials.gov/ct2/show/NCT04746781.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/28884.
超过8800万美国人有患2型糖尿病(T2DM)的风险。国家糖尿病预防计划的生活方式改变计划(DPP LCP)已被证明能有效降低从糖尿病前期进展为T2DM的风险。然而,大多数能从该计划中受益的人并未登记参加。
本试验旨在测试3种基于手机的方法在提高DPP LCP登记率方面的实际效果,其中包括一种最佳实践方案和2种新方法。
我们将进行一项三臂随机临床试验,比较来自2个医疗保健机构的糖尿病前期成年人参加DPP LCP的登记情况和1个月的参与度。最佳实践方案组的参与者将收到基于短信的通知,告知他们患有糖尿病前期,并收到一个网站链接,该网站解释糖尿病前期、T2DM和DPP LCP。随后将进行一个单项问题调查:“你希望DPP LCP给你打电话进行登记吗?”2个干预组的参与者将接受相同的最佳实践干预,另外还会收到2个手机360°视频,或者由接受过一种名为动机与问题解决(MAPS)的动机辅导方法培训的健康教练提供多达5次简短电话。我们将在干预前和4周后收集糖尿病相关知识、对T2DM风险可控性的信念、T2DM风险认知以及生活方式改变自我效能的测量数据。该研究的主要结局是参加DPP LCP的登记情况和4周内对DPP LCP的参与度。此外,还将收集实施干预所需的人工时数以及参与者对干预措施及其可接受性的反馈。我们的主要假设是,这2种新干预措施将比最佳实践干预导致更高的DPP LCP登记率和参与度。次要假设涉及2个干预组的作用机制:(1)在移动手机360°视频组中,风险认知的变化是否与项目登记有关;(2)在MAPS辅导组中,生活方式改变自我效能的变化是否与项目登记有关。最后,探索性分析将考察干预措施的成本效益和可接受性。
该项目于2020年9月获得资助;2021年2月开始招募,预计将持续到2022年7月。
我们正在对2种新颖、可扩展的基于手机的干预措施进行测试,以提高DPP LCP的登记率。如果有效,它们有极大的潜力扩大规模,以帮助在全国范围内预防T2DM。
ClinicalTrials.gov NCT04746781;https://clinicaltrials.gov/ct2/show/NCT04746781。
国际注册报告识别码(IRRID):DERR1-10.2196/28884。